数字培训包对马拉维指数病例测试计划临床结果的影响:一个集群随机对照试验
Nora Rosenberg1, Katie Mollan2,3, Jiayu Wang4
1Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
BMJ global health
|March 13, 2026
概括
增强的数字培训改善了马拉维的艾滋病毒病例发现,显著增加了卫生工作者之间的联系人追踪和自我测试套件的供应. 这种可扩展的方法显示出在扩大低收入环境中的干预措施的前景.
科学领域:
- 公共卫生 公共卫生
- 数字健康干预措施 数字健康干预措施
- 艾滋病毒/艾滋病预防和治疗
背景情况:
- 卫生工作者培训对于实施基于证据的干预措施至关重要.
- 数字培训为低收入环境中的卫生工作者教育提供了可扩展的解决方案.
- 在低收入国家评估数字培训的临床结果是必不可少的,但很少做.
研究的目的:
- 评估马拉维艾滋病毒指数病例测试计划中为卫生工作者提供增强数字培训包的临床结果.
- 评估数字培训对艾滋病毒指数病例测试计划中关键绩效指标的影响.
主要方法:
- 一个集群随机对照试验,涉及马拉维33个卫生机构.
- 卫生机构被随机分配到标准培训或标准培训加数字包.
- 在一年内评估了五个共同初级结果,包括接触诱导,测试,新诊断和自我测试套件的提供.
主要成果:
- 增强的数字培训显著改善了联系客户引发 (RR=1.37),联系客户测试 (RR=1.45) 和自测套件提供 (RR=2.29).
- 对指数客户参与和新的艾滋病毒诊断观察到积极的趋势,尽管在统计学上并不显著.
- 没有任何不良事件与数字培训干预相关.
结论:
- 增强的数字培训对马拉维艾滋病毒计划的关键临床结果产生了积极影响.
- 数字培训方法是扩大基于证据的干预措施在类似环境中的可行和潜在可复制的策略.
相关概念视频
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...